Patents by Inventor Yea Eun Kang

Yea Eun Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12064441
    Abstract: Provided are a composition for treating or preventing recurrence of keloid comprising tauroursodeoxycholic acid as an active ingredient, and a method for treating keloid or preventing recurrence of keloid using the composition.
    Type: Grant
    Filed: August 9, 2022
    Date of Patent: August 20, 2024
    Assignees: CHUNGNAM NATIONAL UNIVERSITY HOSPITAL, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
    Inventors: Yea Eun Kang, Sang-Ha Oh, Sunje Kim, Seong Eun Lee, Shinae Yi, Mi Ae Lim
  • Publication number: 20230257828
    Abstract: The present invention relates to a composition for diagnosis or prognosis prediction of thyroid cancer, which includes an agent for measuring the expression level of mRNA of ADM2 gene or a protein thereof, a kit for diagnosis or prognosis prediction of thyroid cancer, which includes the composition, and a method for providing information for diagnosis or prognosis prediction of thyroid cancer using the composition or the kit.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 17, 2023
    Inventors: Minho Shong, Yea Eun Kang
  • Publication number: 20230046998
    Abstract: Provided are a composition for treating or preventing recurrence of keloid comprising tauroursodeoxycholic acid as an active ingredient, and a method for treating keloid or preventing recurrence of keloid using the composition.
    Type: Application
    Filed: August 9, 2022
    Publication date: February 16, 2023
    Applicants: CHUNGNAM NATIONAL UNIVERSITY HOSPITAL, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
    Inventors: Yea Eun KANG, Sang-Ha OH, Sunje KIM, Seong Eun LEE, Shinae YI, Mi Ae LIM
  • Publication number: 20200232039
    Abstract: The present invention relates to a composition for diagnosis or prognosis prediction of thyroid cancer, which includes an agent for measuring the expression level of mRNA of ADM2 gene or a protein thereof, a kit for diagnosis or prognosis prediction of thyroid cancer, which includes the composition, and a method for providing information for diagnosis or prognosis prediction of thyroid cancer using the composition or the kit.
    Type: Application
    Filed: June 19, 2019
    Publication date: July 23, 2020
    Inventors: Minho Shong, Yea Eun Kang, Jeong Ho Lee, Hyun Yong Koh, Hyun Jung Kim